Works matching AU Aoyama, Togo


Results: 12
    1

    Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease.

    Published in:
    Hypertension Research, 2024, v. 47, n. 3, p. 628, doi. 10.1038/s41440-023-01464-y
    By:
    • Tsukamoto, Shunichiro;
    • Kobayashi, Kazuo;
    • Toyoda, Masao;
    • Hatori, Nobuo;
    • Kanaoka, Tomohiko;
    • Wakui, Hiromichi;
    • Sakai, Hiroyuki;
    • Furuki, Takayuki;
    • Chin, Keiichi;
    • Ito, Shun;
    • Suzuki, Daisuke;
    • Umezono, Tomoya;
    • Aoyama, Togo;
    • Nakajima, Shinichi;
    • Hishiki, Toshimasa;
    • Hatori, Yutaka;
    • Hayashi, Masahiro;
    • Shimura, Hidetoshi;
    • Minagawa, Fuyuki;
    • Mokubo, Atsuko
    Publication type:
    Article
    2
    3

    Blood pressure after treatment with sodium–glucose cotransporter 2 inhibitors influences renal composite outcome: Analysis using propensity score‐matched models.

    Published in:
    Journal of Diabetes Investigation, 2021, v. 12, n. 1, p. 74, doi. 10.1111/jdi.13318
    By:
    • Kobayashi, Kazuo;
    • Toyoda, Masao;
    • Hatori, Nobuo;
    • Furuki, Takayuki;
    • Sakai, Hiroyuki;
    • Umezono, Tomoya;
    • Ito, Shun;
    • Suzuki, Daisuke;
    • Takeda, Hiroshi;
    • Minagawa, Fuyuki;
    • Degawa, Hisakazu;
    • Yamamoto, Hareaki;
    • Machimura, Hideo;
    • Chin, Keiichi;
    • Hishiki, Toshimasa;
    • Takihata, Masahiro;
    • Aoyama, Kouta;
    • Umezawa, Shinichi;
    • Minamisawa, Kohsuke;
    • Aoyama, Togo
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12